Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A voluntary safety recall of widely used Alaris infusion ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued a voluntary recall related to certain Alaris™ and BD Alaris™ Pump Modules that may have been ...
A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.
The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris ...
Feb 6 (Reuters) - Cardinal Health Inc. said it reached an agreement with the U.S. Food and Drug Administration on a consent decree regarding its Alaris infusion pumps. The agreement, which is subject ...
FRANKLIN LAKES, N.J., Aug. 20, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on a previously announced ...
Co announces it has reached an agreement with the F.D.A on a consent decree regarding its Alaris SE line of infusion pumps. The agreement, which is subject to approval by the U.S. District Court for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback